Patients’ approach to medicines in COVID-19

• DOI: 10.52142/omujecm.39.1.21
• Publication Date: 2022-09-28T08:45:48Z
• Authors: Duygu ZORLU; Ali BULUT; Lokman HIZMALI; Gülhan ÜNLÜ
• Keywords: Favipiravir; Hydroxychloroquine; Pandemic

Several different guidelines and therapeutic recommendations have been reported for the treatment of COVID-19 since announcement pandemic. In our study, attitudes approaches patients with a medical indication who were given drugs towards drug usage evaluated. We aimed to present data on characteristics contribute literature. A total 399 included in study. 51.1% female, 48.9% male. The highest number 18-30 age group (27.6%), lowest 65 years old or older (9.8%). Twenty-five questions prepared by researchers asked evaluate "their knowledge disease prevention COVID-19." Of patients, 75.7% not smokers. No history chronic was 65.5% patients. It determined that no recommended 9.8% hydroxychloroquine favipiravir together 49.9%. rate use chloroquine alone 4.8%, using only 32.8%. Eighty-two percent they regularly used recommended. Among 11.5% either never did them at dose time. 46 (11.5%) prescribed regularly, none died. other words, improvement observed them. Our aim this study determine physicians diagnosed cross-sectional sample Turkey, it sufficient city where carried out.